TY - JOUR
T1 - Predicting referral need for febrile children in low-resource community settings in South and Southeast Asia
AU - Spot Sepsis Investigator Group
AU - Chandna, Arjun
AU - Koshiaris, Constantinos
AU - Mahajan, Raman
AU - Ahmad, Riris Adono
AU - Thi Van Anh, Dinh
AU - Choudhury, Khalid Shams
AU - Keang, Suy
AU - Phung, Nguyen The Nguyen
AU - Rattanavong, Sayaphet
AU - Vannachone, Souphaphone
AU - Yuniastuti, Asri
AU - Watson, James A.
AU - Vongsouvath, Manivanh
AU - Vongpromek, Ranitha
AU - Vinitsorn, Asama
AU - Turner, Claudia
AU - Tran, Bang Huyen
AU - Thongpiam, Watcharintorn
AU - Tanunchai, Phattaranit
AU - Souvannasing, Phouthalavanh
AU - Shomik, Mohammad
AU - Sambou, Bran
AU - Rekart, Michael
AU - Pongvongsa, Tiengkham
AU - Phamisith, Chanthala
AU - Phaiphichit, Chom
AU - Perera-Salazar, Rafael
AU - Nguyen, Phung Nguyen The
AU - Menggred, Chonticha
AU - Malavong, Saysamone
AU - Luan, Nguyen Huy
AU - Lasry, Estrella
AU - Kunlaya, Khamfong
AU - Khamboocha, Rungnapa
AU - Keomany, Sommay
AU - Karyana, Muhammad
AU - Kain, Kevin
AU - Jimenez, Carolina
AU - Ghosh, Prakash
AU - Dondorp, Arjen M.
AU - Day, Nicholas P.J.
AU - Dat, Vu Quoc
AU - Dat, Tran Quoc
AU - Chanpheaktra, Ngoun
AU - Boutthasavong, Latsaniphone
AU - Blacksell, Stuart D.
AU - Batty, Elizabeth M.
AU - Painter, Chris
AU - Yosia, Mikhael
AU - Thaipadungpanit, Janjira
N1 - Publisher Copyright:
© The Author(s) 2026.
PY - 2026/5
Y1 - 2026/5
N2 - In resource-constrained community settings, identifying which febrile children require referral remains a major unmet need. Current World Health Organization (WHO) danger signs have limited accuracy, resulting in missed severe illness and unnecessary referrals. Here we developed and validated clinical prediction models to support referral decisions using data from 3,405 children aged 1−59 months presenting with community-acquired acute febrile illnesses to seven hospitals across Bangladesh, Cambodia, Indonesia, Laos and Vietnam. Cambodian data were held out for external validation. The model using simple clinical parameters (sensitivity 74.7% (95% confidence interval (CI): 59.4−88.1); specificity 99.1% (95% CI: 97.7−99.7)) outperformed WHO criteria (sensitivity 55.5% (95% CI: 39.4−72.7); specificity 82.6% (95% CI: 77.1−87.6)) for identification of children at risk of severe disease (death or organ support within 2 days). Including either pulse oximetry or the host biomarker soluble TREM1 (sTREM1) increased sensitivity to 88.9% (95% CI: 76.7−97.8; pulse oximetry) and 89.2% (95% CI: 76.9−97.5; sTREM1), respectively. The pulse oximetry-based model achieved these gains with a threefold reduction in referral rates. These approaches appear cost-effective (pulse oximetry incremental cost effectiveness ratio (ICER) = $26.28; sTREM1 ICER = $196.46) and could improve triage for febrile illness in low-resource settings by enabling more accurate referral decisions. They warrant evaluation in community-based trials.
AB - In resource-constrained community settings, identifying which febrile children require referral remains a major unmet need. Current World Health Organization (WHO) danger signs have limited accuracy, resulting in missed severe illness and unnecessary referrals. Here we developed and validated clinical prediction models to support referral decisions using data from 3,405 children aged 1−59 months presenting with community-acquired acute febrile illnesses to seven hospitals across Bangladesh, Cambodia, Indonesia, Laos and Vietnam. Cambodian data were held out for external validation. The model using simple clinical parameters (sensitivity 74.7% (95% confidence interval (CI): 59.4−88.1); specificity 99.1% (95% CI: 97.7−99.7)) outperformed WHO criteria (sensitivity 55.5% (95% CI: 39.4−72.7); specificity 82.6% (95% CI: 77.1−87.6)) for identification of children at risk of severe disease (death or organ support within 2 days). Including either pulse oximetry or the host biomarker soluble TREM1 (sTREM1) increased sensitivity to 88.9% (95% CI: 76.7−97.8; pulse oximetry) and 89.2% (95% CI: 76.9−97.5; sTREM1), respectively. The pulse oximetry-based model achieved these gains with a threefold reduction in referral rates. These approaches appear cost-effective (pulse oximetry incremental cost effectiveness ratio (ICER) = $26.28; sTREM1 ICER = $196.46) and could improve triage for febrile illness in low-resource settings by enabling more accurate referral decisions. They warrant evaluation in community-based trials.
UR - https://www.scopus.com/pages/publications/105038704483
U2 - 10.1038/s41591-026-04338-1
DO - 10.1038/s41591-026-04338-1
M3 - Article
C2 - 42056495
AN - SCOPUS:105038704483
SN - 1078-8956
VL - 32
SP - 1907
EP - 1916
JO - Nature Medicine
JF - Nature Medicine
IS - 5
ER -